Skip to main content
Caplight Logo









Dingxin Capital

Dingxin Capital

Shenzhen, Guangdongdingxin-capital.com

Overview

Dingxin Capital is a venture capital and private equity firm founded in 2014. It focuses on early-stage investments in the healthcare and hard technology sectors, including TMT, biotechnology, and semiconductors. The firm's core team has a background in finance, healthcare, semiconductors, and communications. The firm is an active investor and is a member of the Shenzhen Venture Capital Association.

Portfolio Companies

18

Investments

Dingxin Capital investments
CompanyDateStageLead
Suzhou Legendsemi Technology Co., Ltd.Jun 2023Series ACo-investor
ZhiHe Biotechnology (Changzhou) Co., Ltd.May 2024Pre SeedCo-investor
Chenzhi SemiconductorMay 2023Series CCo-investor
IMPACT TherapeuticsMar 2022Series DCo-investor
Shanghai Xinjian Medical Technology Co., Ltd.Apr 2018Series ACo-investor
Book a demo to see all investments

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Book a demo to explore sector, stage, and valuation breakdowns for this investor.

Book a demo

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Book a demo to explore yearly investment trends and funding raised over time.

Book a demo

For institutional investors. Book with your work email.

FAQ

Where is Dingxin Capital based?

Dingxin Capital is headquartered in Shenzhen, Guangdong, China.

When was Dingxin Capital founded?

Founding year information for Dingxin Capital is not publicly available.

How many portfolio companies does Dingxin Capital have?

Dingxin Capital has 18 portfolio companies in Caplight's dataset.

What are some companies in Dingxin Capital's portfolio?

Portfolio companies visible on Caplight include Suzhou Legendsemi Technology Co., Ltd., ZhiHe Biotechnology (Changzhou) Co., Ltd., Chenzhi Semiconductor, IMPACT Therapeutics, Shanghai Xinjian Medical Technology Co., Ltd..

What was Dingxin Capital's most recent investment shown here?

Dingxin Capital's most recent investment in this portfolio sample was in ZhiHe Biotechnology (Changzhou) Co., Ltd. in 2024.

What sectors does Dingxin Capital focus on?

Dingxin Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Telecommunications & Networking, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Telecommunications & Networking, Frontier & Industrial Tech, Frontier & Industrial Tech, Mobility, Transportation & Logistics, Energy & Sustainability, Telecommunications & Networking, Telecommunications & Networking, Energy & Sustainability, Enterprise Software, Telecommunications & Networking, Frontier & Industrial Tech, Frontier & Industrial Tech.

What company stages does Dingxin Capital focus on?

Dingxin Capital typically invests at the MultiStage stage.

Firmographic Details

HeadquartersShenzhen, Guangdong
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?